全文获取类型
收费全文 | 7703篇 |
免费 | 455篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 300篇 |
妇产科学 | 180篇 |
基础医学 | 1301篇 |
口腔科学 | 108篇 |
临床医学 | 601篇 |
内科学 | 1872篇 |
皮肤病学 | 178篇 |
神经病学 | 794篇 |
特种医学 | 146篇 |
外科学 | 629篇 |
综合类 | 23篇 |
预防医学 | 669篇 |
眼科学 | 156篇 |
药学 | 586篇 |
中国医学 | 37篇 |
肿瘤学 | 552篇 |
出版年
2024年 | 7篇 |
2023年 | 54篇 |
2022年 | 168篇 |
2021年 | 280篇 |
2020年 | 163篇 |
2019年 | 224篇 |
2018年 | 240篇 |
2017年 | 201篇 |
2016年 | 206篇 |
2015年 | 245篇 |
2014年 | 327篇 |
2013年 | 399篇 |
2012年 | 630篇 |
2011年 | 634篇 |
2010年 | 323篇 |
2009年 | 269篇 |
2008年 | 482篇 |
2007年 | 536篇 |
2006年 | 504篇 |
2005年 | 464篇 |
2004年 | 432篇 |
2003年 | 387篇 |
2002年 | 364篇 |
2001年 | 42篇 |
2000年 | 29篇 |
1999年 | 48篇 |
1998年 | 69篇 |
1997年 | 62篇 |
1996年 | 47篇 |
1995年 | 48篇 |
1994年 | 35篇 |
1993年 | 37篇 |
1992年 | 32篇 |
1991年 | 24篇 |
1990年 | 19篇 |
1989年 | 14篇 |
1988年 | 21篇 |
1987年 | 16篇 |
1986年 | 18篇 |
1985年 | 8篇 |
1984年 | 12篇 |
1983年 | 11篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1974年 | 5篇 |
1970年 | 5篇 |
1967年 | 5篇 |
排序方式: 共有8212条查询结果,搜索用时 15 毫秒
71.
Joseane C. de Castro Laila V. de Almeida Mariana Santos Cardoso Fabricio M. Silva Oliveira Denise S. Nogueira João Luis Reis-Cunha Luisa M.D. Magalhaes Bin Zhan Maria Elena Bottazzi Peter J. Hotez Lilian L. Bueno Daniella Castanheira Bartholomeu Ricardo T. Fujiwara 《Vaccine》2021,39(2):394-401
An estimated 400 million people are infected by parasites of the genus Ascaris and the existing control measures are inefficient. Vaccine development using B cell antigens is a promising strategy for increased protection against this parasite. The present study aimed at developing a chimeric protein capable of conferring protection against infection by Ascaris sp. For this purpose, we performed B-cell epitope predictions on previously described vaccine candidate proteins from Ascaris suum and the corresponding peptides were used to construct a chimeric protein. Female BALB / c mice were immunized subcutaneously in three doses at 10 day intervals with a vaccine formulation comprised of the chimeric protein together with monophosphoryl lipid A (MPLA). Control groups included protein alone, MPLA, or PBS. After challenge infection, animals vaccinated with chimeric protein plus MPLA showed a reduction of 73.54% of larval load in the lung compared to control group animals. Animals immunized with chimeric protein plus MPLA also display higher IgG response and a reduction in lung inflammation. Our study highlights how chimeric proteins containing more than one B cell epitope can enhance immune protection against helminthic infection and offer new approaches to the development of Ascaris vaccines. 相似文献
72.
Ostinelli Edoardo G. D’Agostino Armando Pesce Luisa Zangani Caroline Miragoli Paolo Durbano Federico Biffi Giuseppe Mencacci Claudio Scarone Silvio Gambini Orsola 《Zeitschrift fur Gesundheitswissenschaften》2021,29(6):1343-1355
Journal of Public Health - Neighbourhood composition is considered a social determinant of mental health that can be addressed by policymakers to improve outcomes. Deprived neighbourhoods typically... 相似文献
73.
SMC1 involvement in fragile site expression 总被引:2,自引:0,他引:2
Musio A Montagna C Mariani T Tilenni M Focarelli ML Brait L Indino E Benedetti PA Chessa L Albertini A Ried T Vezzoni P 《Human molecular genetics》2005,14(4):525-533
Common fragile sites have been involved in neoplastic transformation, although their molecular basis is still poorly understood. Here, we demonstrate that inhibition of the SMC1 by RNAi is sufficient to induce fragile site expression. By investigating normal, ATM- and ATR-deficient cell lines, we provide evidence that the contribution of SMC1 in preventing the collapse of stalled replication fork is an Atr-dependent pathway. Using a fluorescent antibody specific for gamma-H2AX, we show that very rare discrete nuclear foci appear 1 and 2 h after exposure to aphidicolin and/or RNAi-SMC1, but became more numerous and distinct after longer treatment times. In this context, fragile sites might be viewed as an in vitro phenomenon originating from double-strand breaks formed because of a stalled DNA replication that lasted too long to be managed by physiological rescue acting through the Atr/Smc1 axis. We propose that in vivo, following an extreme replication block, rare cells could escape checkpoint mechanisms and enter mitosis with a defect in genome assembly, eventually leading to neoplastic transformation. 相似文献
74.
75.
76.
Luisa Zanette Massimo Zucchetti Andrea Freshi Domenico Erranti Umberto Tirelli Maurizio D'Incalci 《Cancer chemotherapy and pharmacology》1990,25(6):445-448
Summary The clinical pharmacokinetics of 4-demethoxydaunorubicin was investigated in 28 cancer patients who received the drug orally. The majority of the patients were elderly (median age, 72 years). Nine of them also received an i. v. dose, and the bioavailability of the oral dose ranged between 9% and 39%. 4-Demethoxydaunorubicin peak levels were achieved 2–4 h after the oral dose in most patients. The drug was rapidly and extensively metabolized to 4-demethoxy-13-hydroxydaunorubicin, which is probably as active as the parent drug. The metabolite levels were much higher and longer lasting than the parent drug, suggesting that it may play an important role in the drug's pharmacological effects. 相似文献
77.
Luciano Saso Giovanni Valentini Eleonora Mattei Claudio Panzironi Maria Luisa Casini Eleonora Grippa Bruno Silvestrini 《Archives of pharmacal research》1999,22(5):485-490
The mechanism of action of fish oil (FO), currently used in different chronic inflammatory conditions such as rheumatoid arthritis (RA), is not completely understood, although it is thought that it could alter the metabolism of endogenous autacoids. In addition, we hypothesized that the known capability of fatty acids (FA) of stabilizing serum albumin and perhaps other proteins, may be of pharmacological relevance considering that it is shared by other anti-rheumatic agents (e.g. nonsteroidal antiinflammatory drugs). Thus, we studied the effect of oral administration of FO and corn oil (CO), a vegetable oil with a different composition, on the stability of rat serum proteins, evaluated by a classical in vitro method based on heat-induced protein denaturation. FO, and, to a lower extent, CO inhibited heat-induced denaturation of rat serum (RS): based on the inhibitory activity (EC50) of the major fatty acids against heat-induced denaturation of RS in vitro, it was possible to speculate that in vivo effects of palmitic acid (C16:0) and eicosapentaenoic acid (EPA, C20:5, n-3) may be more relevant than that of linolenic acid (C18:2). To better investigate this phenomenon, we extracted albumin from the serum of animals treated or not with FO with a one-step affinity chromatography technique, obtaining high purity rat serum albumin preparations (RSA-CTRL and RSA-FO), as judged by SDS-PAGE with Coomassie blue staining. When these RSA preparations were heated at 70 degrees C for 30 min, it was noted that RSA-FO was much more stable than RSA-CTRL, presumably due to higher number of long chain fatty acids (FA) such as palmitic acid or EPA. In conclusion, we provided evidences that oral administration of FO in the rat stabilizes serum albumin, due to an increase in the number of protein bound long chain fatty acids (e.g. palmitic acid and EPA). We speculate that the stabilization of serum albumin and perhaps other proteins could prevent changes of antigenicity due to protein denaturation and glycosylation, which may trigger pathological autoimmune responses, suggesting that this action may be involved in the mode of action of FO in RA and other chronic inflammatory diseases. 相似文献
78.
M. Luisa Calonge Anunciación A. Ilundáin 《Pflügers Archiv : European journal of physiology》1996,431(4):594-598
Chicken enterocytes present a H+-conducting pathway involved in the recovery of intracellular pH (pHi) from an acid load. In the current study we have tested the effect of protein kinase C (PKC) activators on the rate of proton efflux through the H+-conducting pathway. The rate of proton efflux was increased by the addition of 1,2-dioctanoyl-rac-glycerol (DOG) or phorbol 12-myristate 13-acetate (PMA), but it was not affected by the addition of the inactive phorbol ester analogue, 4-phorbol 12, 13-didecanoate. DOG stimulated the process in a dose-dependent manner with a half-maximal effect at 45 M. Staurosporine and Zn2+ prevented the DOG-dependent increase in the rate of proton efflux. The rate of proton efflux was affected by the pHi and DOG shifted this relationship upward and to the right. These results suggest that the proton-conducting pathway is regulated by PKC. 相似文献
79.
Prof. Dr. J. Simões da Fonseca M. Teresa Gil M. Luisa Figueira J. Guerreiro Barata Fernando Pego M. Fernanda Pacheco 《European archives of psychiatry and clinical neuroscience》1978,225(1):31-53
Summary The authors studied the behavior of normal subjects and paranoid schizophrenic patients in a simple problem-solving situation. The schizophrenics were divided into two sample groups, one of individuals under treatment and the other of individuals not under treatment.The learning process involved in this problem-solving situation is very similar to an instrumental conditioning, and can be understood by means of the following assumptions: (1) the subjects use decision functions in reacting to the stimuli, although they may be not fully aware of this; (2) learning is the result of successive transformations of these decisions in the course of time; (3) the changes have specific probabilities and are related to (a) those responses which are made to the latest stimuli, and (b) a differential probability for decision functions which were effective, or only interrupted painful reinforcement, or were completely ineffective.In schizophrenics further factors of importance were (1) an inertia factor and (2) the rigidly continued use of unsuccessful or only partially successful decision criteria.The authors used a systems theory based on Galois field theory and a calculus of operators specifying three groups of subjects. A computer program based on these hypotheses was tested in a simulation experiment.The statistical evaluation of the results showed a congruence between the theoretical approach and the experimental data.This work was carried out with financial support from the Institute de Alta Cultura, Lisbon, between 1970 and 1974 相似文献
80.
Chlorpyrifos-induced delayed polyneuropathy 总被引:1,自引:0,他引:1
Eugenio Capodicasa Maria Luisa Scapellato Angelo Moretto Stefano Caroldi Marcello Lotti 《Archives of toxicology》1991,65(2):150-155
Chlorpyrifos [0,0-diethyl 0-(3,5,6-trichloro-pyridyl) phosphorothioate] caused delayed polyneuropathy in man. Contrary to previous studies, we report here that it also causes delayed polyneuropathy in the hen, the animal model for this toxicity. The minimal neuropathic dose was 60–90 mg/kg p.o., corresponding to 4–6 times the estimated LD50. Consequently, pralidoxime (2-PAM) in conjunction with atropine was necessary to reverse acetylcholinesterase (AChE) inhibition and cholinergic toxicity in hens given high enough doses of chlorpyrifos to cause neuropathy. Chlorpyrifos was slowly absorbed after single oral doses and the threshold of inhibition (>70%) of neuropathy target esterase (NTE), the putative target for delayed neuropathy, was reached within 5–6 days. High AChE inhibition (>90%), however, was measured within hours after dosing because of the higher potency of chlorpyrifos to inhibit this enzyme. In vitro studies showed that chlorpyrifos-oxon, the active metabolite of chlorpyrifos, was 10–20 times more active against AChE than against NTE, confirming the clinical observation. No differences were seen between human and hen enzymes in this respect. Hen and human brain homogenates contain A-esterases which hydrolysed chlorpyrifos to about the same extent in both species. In conclusion, chlorpyrifos causes delayed polyneuropathy in the hen, as was reported in man. The reasons for previous negative data in the hen are probably due to the relatively lower doses which were used. Judging from in vitro studies with hen and human enzymes, there are no differences in the two species as far as their relative sensitivity to delayed polyneuropathy. It is likely that delayed polyneuropathy would develop in both species only after severe cholinergic toxicity requiring aggressive antidotal treatment.Part of this work was presented at the 25th Annual Meeting of the Society of Toxicology held in New Orleans, LA, USA, March 1986, at the International Symposium on Biochemical and Cellular Indices of Toxicity in Occupational and Environmental Medicine held in Milan, Italy, June 1986, and at the 9th Meeting of the Peripheral Nerve Study Group, Praglia (PD), Italy, August – September, 1989 相似文献